Pamela Pavco
CIK 1426651 · View on SEC EDGAR ↗
First SEC filing: May 3, 2013 · Latest: May 3, 2013
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 1, 2017 | PHIO | A | 7,000 | — | — | 7,000 Direct | — | Acquired | (price as of 2026-08-21) |
| Dec. 16, 2016 | PHIO | A | 11,111 | — | — | 11,111 Direct | — | Acquired | (price as of 2026-08-21) |
| Dec. 16, 2016 | PHIO | A | 11,111 | $0.90 | $10,000 | 17,173 Direct | +183.29% | Acquired | -100.0% (price as of 2026-08-21) |
| Feb. 10, 2016 | PHIO | A | 66,000 | — | — | 66,000 Direct | — | Acquired | (price as of 2026-08-21) |
| June 2, 2015 | PHIO | A | 6,250 | — | — | 6,250 Direct | — | Acquired | (price as of 2026-08-21) |
| June 2, 2015 | PHIO | A | 6,250 | — | — | 6,250 Direct | — | Acquired | (price as of 2026-08-21) |
| June 2, 2015 | PHIO | A | 12,500 | $0.40 | $5,000 | 33,718 Direct | +58.91% | Acquired | -100.0% (price as of 2026-08-21) |
| June 1, 2015 | PHIO | A | 66,000 | — | — | 66,000 Direct | — | Acquired | (price as of 2026-08-21) |
| June 2, 2014 | PHIO | A | 66,000 | — | — | 66,000 Direct | — | Acquired | (price as of 2026-08-21) |
| June 7, 2013 | PHIO | A | 2,000,000 | — | — | 2,000,000 Direct | — | Acquired | (price as of 2026-08-21) |
| Sept. 24, 2011 | SLS | A | 150,000 | — | — | 150,000 Direct | — | Acquired | (price as of 2026-08-21) |
| March 15, 2011 | SLS | A | 33,563 | — | — | 44,940 Direct | +295.01% | Acquired | (price as of 2026-08-21) |
| July 15, 2010 | SLS | A | 5,000 | $2.38 | $11,900 | 11,377 Direct | +78.41% | Acquired | -100.0% (price as of 2026-08-21) |
| April 15, 2010 | SLS | A | 15,000 | — | — | 15,000 Direct | — | Acquired | (price as of 2026-08-21) |
| Jan. 20, 2010 | SLS | A | 6,377 | — | — | 6,377 Direct | — | Acquired | (price as of 2026-08-21) |
| Jan. 14, 2010 | SLS | A | 28,054 | — | — | 28,054 Direct | — | Acquired | (price as of 2026-08-21) |
| Jan. 15, 2009 | SLS | A | 47,000 | — | — | 234,137 Direct | +25.12% | Acquired | (price as of 2026-08-21) |
| April 18, 2008 | SLS | A | 41,826 | — | — | 41,826 Direct | — | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 1, 2017 | PHIO | Stock option (right to buy) | Common Stock (7,000) | $0.63 | Feb. 1, 2027 | 7,000 | Acquired |
| Dec. 16, 2016 | PHIO | Common stock warrant | Common stock (11,111) | $0.90 | Dec. 21, 2021 | 11,111 | Acquired |
| Feb. 10, 2016 | PHIO | Stock option (right to buy) | Common stock (66,000) | $0.29 | Feb. 10, 2026 | 66,000 | Acquired |
| June 2, 2015 | PHIO | Common stock purchase warrant | Common stock (6,250) | $0.52 | June 2, 2020 | 6,250 | Acquired |
| June 2, 2015 | PHIO | Overallotment purchase right | Common stock (6,250) | $0.46 | July 2, 2016 | 6,250 | Acquired |
| June 1, 2015 | PHIO | Stock option (right to buy) | Common stock (66,000) | $0.38 | June 1, 2025 | 66,000 | Acquired |
| June 2, 2014 | PHIO | Stock Option (right to buy) | Common stock (66,000) | $2.85 | June 2, 2024 | 66,000 | Acquired |
| June 7, 2013 | PHIO | Stock Option (right to buy) | Common Stock (2,000,000) | $0.20 | June 7, 2023 | 2,000,000 | Acquired |
| Sept. 24, 2011 | SLS | Stock Option (right to buy) [F1] | Common Stock (150,000) | $0.65 | Sept. 24, 2021 | 150,000 | Acquired |
| April 15, 2010 | SLS | Stock Option [F1] | Common Stock (15,000) | — | April 14, 2020 | 15,000 | Acquired |
| Jan. 14, 2010 | SLS | Stock Option [F1] | Common Stock (28,054) | — | Jan. 14, 2020 | 28,054 | Acquired |
| Jan. 15, 2009 | SLS | Stock Option [F1] | Common Stock (47,000) | — | Jan. 15, 2019 | 47,000 | Acquired |
| April 18, 2008 | SLS | Incentive Stock Option [F1] | Common Stock (41,826) | $7.50 | April 18, 2018 | 41,826 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 4 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| May 3, 2013 | PHIO | Stock Option (right to buy)→ Common stock (16,742,743) | 16,742,743 | Direct |
| March 1, 2013 | PHIO | Common stock, par value $0.0001 | 90,153 | Direct |
| March 1, 2013 | PHIO | Stock Option (right to buy)→ Common stock (16,742,743) | 16,742,743 | Direct |
| Feb. 14, 2008 | SLS | Incentive Stock Option (right to buy) [F1]→ Common Stock (145,311) | 145,311 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2011 | $292,500 | $7,255 | — | — | — | — | $300 | $374,245 |
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2017 | $196,471 | — | — | — | — | — | $228 | $199,854 |
| 2016 | $377,522 | — | — | — | $108,186 | — | $585 | $499,493 |
| 2015 | $363,808 | — | — | — | $104,025 | — | $300 | $486,613 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.